Bevacizumab in treatment of high-risk ovarian cancer--a cost-effectiveness analysis.
Chan JK; Herzog TJ; Hu L; Monk BJ; Kiet T; Blansit K; Kapp DS; Yu X; The Oncologist, 2014, vol. 19, issue 5, p 523, ISSN 1549490x. ISBN 1549490x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef